Show simple item record

dc.contributor.authorKurane, Ichiro
dc.contributor.authorMatsutani, Takaji
dc.contributor.authorSuzuki, Ryuji
dc.contributor.authorTakasaki, Tomohiko
dc.contributor.authorKalayanarooj, Siripen
dc.contributor.authorGreen, Sharone
dc.contributor.authorRothman, Alan L.
dc.contributor.authorEnnis, Francis A.
dc.date2022-08-11T08:11:05.000
dc.date.accessioned2022-08-23T17:32:35Z
dc.date.available2022-08-23T17:32:35Z
dc.date.issued2011-12-01
dc.date.submitted2012-06-22
dc.identifier.citationTrop Med Health. 2011 Dec;39(4 Suppl):45-51. Epub 2011 Dec 1. <a href="http://dx.doi.org/10.2149/tmh.2011-S09">Link to article on publisher's site</a>
dc.identifier.issn1348-8945 (Linking)
dc.identifier.doi10.2149/tmh.2011-S09
dc.identifier.pmid22500136
dc.identifier.urihttp://hdl.handle.net/20.500.14038/50983
dc.description.abstractDengue virus (DENV) is a leading cause of morbidity and mortality in most tropical and subtropical areas of the world. Dengue virus infection induces specific CD4+CD8- and CD8+CD4- T cells in humans. In primary infection, T-cell responses to DENV are serotype cross-reactive, but the highest response is to the serotype that caused the infection. The epitopes recognized by DENV-specific T cells are located in most of the structural and non-structural proteins, but NS3 is the protein that is most dominantly recognized. In patients with dengue hemorrhagic fever (DHF) caused by secondary DENV infection, T cells are highly activated in vivo. These highly activated T cells are DENV-specific and oligoclonal. Multiple kinds of lymphokines are produced by the activated T cells, and it has been hypothesized that these lymphokines are responsible for induction of plasma leakage, one of the most characteristic features of DHF. Thus, T-cells play important roles in the pathogenesis of DHF and in the recovery from DENV infection.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=22500136&dopt=Abstract">Link to Article in PubMed</a>
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.subjectWomen's Studies
dc.titleT-cell responses to dengue virus in humans
dc.typeJournal Article
dc.source.journaltitleTropical medicine and health
dc.source.volume39
dc.source.issue4 Suppl
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1515&amp;context=wfc_pp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/wfc_pp/516
dc.identifier.contextkey3017573
refterms.dateFOA2022-08-23T17:32:35Z
html.description.abstract<p>Dengue virus (DENV) is a leading cause of morbidity and mortality in most tropical and subtropical areas of the world. Dengue virus infection induces specific CD4+CD8- and CD8+CD4- T cells in humans. In primary infection, T-cell responses to DENV are serotype cross-reactive, but the highest response is to the serotype that caused the infection. The epitopes recognized by DENV-specific T cells are located in most of the structural and non-structural proteins, but NS3 is the protein that is most dominantly recognized. In patients with dengue hemorrhagic fever (DHF) caused by secondary DENV infection, T cells are highly activated in vivo. These highly activated T cells are DENV-specific and oligoclonal. Multiple kinds of lymphokines are produced by the activated T cells, and it has been hypothesized that these lymphokines are responsible for induction of plasma leakage, one of the most characteristic features of DHF. Thus, T-cells play important roles in the pathogenesis of DHF and in the recovery from DENV infection.</p>
dc.identifier.submissionpathwfc_pp/516
dc.contributor.departmentCenter for Infectious Disease and Vaccine Research
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases and Immunology
dc.source.pages45-51


Files in this item

Thumbnail
Name:
tmh_39_4_suppl_45_1_.pdf
Size:
341.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record